Pensatech Pharma GmbH (founded in Berlin, Germany in 2012) is a knowledge- and science- driven research and development company with a comprehensive suite of known and innovative drug delivery technologies offering: 

1) Service on advanced drug formulation with analytical development/ testing

2) Partnering/ out-licensing of in-house developed novel drug products and difficult-to-formulate generics

1) Service on advanced drug formulation with analytical development/ testing

We support you with Preformulation, Formulation and Process Development, Analytical Development, Stability Studies and EU GMP Quality Control & Batch Certification on:

• Long acting injectables (LAI)

  • Microparticles, implants, in-situ implants, drug suspensions

  • Biodegradable (poly(lactide-co-glycolide) (PLGA) and non-degradable (PEVA) polymers and (phospho-)lipids

• Oral modified release (MR) 

  • Enteric, extended, pulsatile, colonic release

  • High dose, FDC, dual release, liquid MR dosage forms

• Bioavailablity enhancement 

  • Nanosuspensions, amorphous solid dispersions (ASD), solubilisation

• Nanocarriers (nanoparticles, nanocrystals, liposomes)

• Local delivery (ophthalmic, topical, nasal, buccal)

  • Solutions, emulsions, suspensions, ointments, gels

• Paediatric/ geriatric formulations

• Stability improvement

• Taste-masking

• APIs: 

  • Small APIs, peptide-/protein-/ oligonucleotide-APIs, highly potent APIs, cytotoxics, controlled substances

2) Partnering or out-licensing

2a) In-house developments

• Ophthalmic: 

  • Dry eye disease (DED)

  • Post-Cataract Inflammation

  • Cataract & Presbiopia

  • Cystinosis 

  • Dexamethasone (Ozurdex®) Intravitreal Implant

• Long Acting Injectables:

  • GLP-1

  • Triptorelin (up to 1 year) 

• Cannabinoids (THC, CBD and others): Novel Modified Release Dosage Forms

2b) Generic developments

• Budesonide (Budenofalk®) Oral Modified Release Pellets (3, 9 mg)

• Long Acting Injectables:

  • Dexamethasone (Ozurdex®) Intravitreal Implant

  • Triptorelin (Decapeptyl®, Pamorelin®) Microparticles (1, 3, 6 months)

  • Goserelin (Zoladex®) Implant (1, 3 months) 

  • Triamcinolone acetonide (Zilretta®) Microparticles

  • Moxidectin (Proheart®) Lipid Microparticles (Animal Health)